id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-N-3930-0001,FDA,FDA-2026-N-3930,Medical Devices; Immunology and Microbiology Devices; Classification of the Alzheimer’s Disease Pathology Assessment Test,Rule,Final Rule,2026-04-22T04:00:00Z,2026,4,,,2026-04-22T17:00:14Z,2026-07860,0,0,09000064b929eb70